/
Gastroenterology
262Diseases↗
705Pipeline Programs↗
1.1KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
3,921
clinical trials
Completed1,950 · 50%
Recruiting588 · 15%
Unknown status444 · 11%
Terminated311 · 8%
Not yet recruiting296 · 8%
Active, not recruiting153 · 4%
Other179 · 5%
Landscape
Diseases
Cirrhosis
Most programs59
Programs
126
Trials
29
Recruiting
Pre
41
P1
1
P2
5
P3
5
Appr
23
Most programs:
Eli Lilly
Eli LillyInflammatory Bowel Disease
Most trials41
Programs
99
Trials
22
Recruiting
Pre
31
P1
5
P2
3
P3
1
Appr
22
Most programs:
Jazz Pharmaceuticals
Jazz PharmaceuticalsPancreatitis
Highest activity54
Programs
83
Trials
12
Recruiting
Pre
17
P1
—
P2
5
P3
2
Appr
10
Most programs:
Novartis
NovartisIrritable Bowel Syndrome
331 programs70 trialsApproved
Fatty Liver Disease
27 programs45 trialsApproved
Esophagitis
22 programs40 trialsApproved
Non-Alcoholic Fatty Liver Disease
115 programs43 trialsApproved
Gastroesophageal Reflux
120 programs36 trialsPhase 1
Cholangitis
1 program55 trialsApproved
Alcoholic Fatty Liver Disease
23 programs32 trialsApproved
Fatty Liver
11 program53 trialsPhase 3
Acute Pancreatitis
123 programs30 trialsApproved
Inguinal Hernia
220 programs32 trialsApproved
Moderately to Severely Active Ulcerative Colitis
11 program51 trialsPhase 3
Gastroesophageal Reflux Disease
118 programs32 trialsApproved
IBD
0 programs50 trials
Dyspepsia
22 programs26 trialsApproved
Hemorrhoid
15 programs33 trialsApproved
Ascites
113 programs29 trialsApproved
Chronic Pancreatitis
11 programs29 trialsApproved
Primary Biliary Cholangitis
211 programs29 trialsApproved
Metabolic Dysfunction-Associated Steatotic Liver Disease
13 programs33 trialsPhase 3
IBS
1 program34 trialsPreclinical
Sclerosing Cholangitis
11 programs21 trialsApproved
Liver Cirrhosis
24 programs28 trialsPhase 3
Celiac Disease
211 programs18 trialsApproved
Peptic Ulcer
18 programs10 trialsApproved
Short Bowel Syndrome
11 programs17 trialsApproved
Barrett's Esophagus
4 programs23 trialsApproved
Primary Sclerosing Cholangitis
4 programs21 trialsPhase 3
Showing top 30 diseases by activity. 232 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)